ZA922297B - Crystalline tiababine monohydrate,its preparation and use - Google Patents
Crystalline tiababine monohydrate,its preparation and useInfo
- Publication number
- ZA922297B ZA922297B ZA922297A ZA922297A ZA922297B ZA 922297 B ZA922297 B ZA 922297B ZA 922297 A ZA922297 A ZA 922297A ZA 922297 A ZA922297 A ZA 922297A ZA 922297 B ZA922297 B ZA 922297B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- monohydrate
- tiababine
- crystalline
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Photoreceptors In Electrophotography (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Transceivers (AREA)
- Mobile Radio Communication Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK91582A DK58291D0 (da) | 1991-04-02 | 1991-04-02 | Krystalinsk stof og dets fremstilling |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA922297B true ZA922297B (en) | 1992-12-30 |
Family
ID=8095193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA922297A ZA922297B (en) | 1991-04-02 | 1992-03-30 | Crystalline tiababine monohydrate,its preparation and use |
Country Status (15)
Country | Link |
---|---|
US (1) | US5354760A (fr) |
EP (1) | EP0579681B1 (fr) |
AT (1) | ATE180781T1 (fr) |
AU (1) | AU661483B2 (fr) |
CA (1) | CA2107223C (fr) |
DE (1) | DE69229339T2 (fr) |
DK (2) | DK58291D0 (fr) |
ES (1) | ES2134801T3 (fr) |
FI (1) | FI110096B (fr) |
GR (1) | GR3030919T3 (fr) |
IL (1) | IL101358A (fr) |
NO (1) | NO304113B1 (fr) |
NZ (1) | NZ242191A (fr) |
WO (1) | WO1992017473A1 (fr) |
ZA (1) | ZA922297B (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750140A (en) * | 1994-05-20 | 1998-05-12 | Novo Nordisk A/S | Transdermal delivery of tiagabine |
MX9708394A (es) * | 1995-05-05 | 1998-02-28 | Novo Nordisk As | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. |
AU736514B2 (en) * | 1995-07-13 | 2001-07-26 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Non-allosteric gabaa agonists for treating sleep disorders |
DE19525598C2 (de) * | 1995-07-13 | 1997-09-25 | Max Planck Gesellschaft | Schlafmittel |
UA52661C2 (uk) * | 1996-06-14 | 2003-01-15 | Ново Нордіск А/С | Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти |
US5914333A (en) * | 1996-07-31 | 1999-06-22 | Novo Nordisk A/S | Treatment of psychotic disorders |
IE970588A1 (en) | 1997-08-01 | 2000-08-23 | Elan Corp Plc | Controlled release pharmaceutical compositions containing tiagabine |
FR2771292B1 (fr) * | 1997-11-21 | 2000-02-18 | Ethypharm Lab Prod Ethiques | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques |
PE20011061A1 (es) | 2000-02-01 | 2001-11-20 | Procter & Gamble | Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato |
PE20011065A1 (es) | 2000-02-01 | 2001-11-21 | Procter & Gamble | Proceso para fabricar bisfosfonatos geminales |
CN1649614A (zh) | 2002-02-22 | 2005-08-03 | 新河药品股份有限公司 | 活性剂传递系统和保护及施用活性剂的方法 |
CN1314684C (zh) * | 2003-12-24 | 2007-05-09 | 中国科学院上海有机化学研究所 | 噻加宾及其消旋体和s-构型的合成方法及其无定形粉末的制法 |
WO2005122698A2 (fr) * | 2003-12-24 | 2005-12-29 | Sun Pharmaceutical Industries Limited | Nouvelles formes polymorphes stables d'un anticonvulsif |
WO2005092886A1 (fr) * | 2004-03-29 | 2005-10-06 | Ranbaxy Laboratories Limited | Procede de preparation d'une forme amorphe de la tiagabine |
WO2006013550A2 (fr) * | 2004-08-04 | 2006-02-09 | Ranbaxy Laboratories Limited | Procede d'elaboration d'acide carboxylique de piperidine |
US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
US20080064727A1 (en) * | 2006-08-18 | 2008-03-13 | Cephalon, Inc. | Crystalline forms of tiagabine hydrochloride |
US20080051435A1 (en) * | 2006-08-18 | 2008-02-28 | Cephalon, Inc. | Crystalline and amorphous forms of tiagabine |
CN101857591B (zh) * | 2009-04-09 | 2013-06-05 | 北京京卫燕康药物研究所有限公司 | 盐酸噻加宾晶型及其制备方法 |
CN103554093B (zh) * | 2013-11-12 | 2015-10-21 | 四川科瑞德凯华制药有限公司 | 噻加宾乙酯盐酸盐及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK288385D0 (da) * | 1985-06-26 | 1985-06-26 | Novo Industri As | Aminosyrederivater |
ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
US4910312A (en) * | 1985-11-08 | 1990-03-20 | Warner-Lambert Company | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof |
-
1991
- 1991-04-02 DK DK91582A patent/DK58291D0/da not_active Application Discontinuation
-
1992
- 1992-03-23 AT AT92908325T patent/ATE180781T1/de active
- 1992-03-23 DE DE69229339T patent/DE69229339T2/de not_active Expired - Lifetime
- 1992-03-23 DK DK92908325T patent/DK0579681T3/da active
- 1992-03-23 ES ES92908325T patent/ES2134801T3/es not_active Expired - Lifetime
- 1992-03-23 EP EP92908325A patent/EP0579681B1/fr not_active Expired - Lifetime
- 1992-03-23 AU AU16415/92A patent/AU661483B2/en not_active Expired
- 1992-03-23 CA CA002107223A patent/CA2107223C/fr not_active Expired - Lifetime
- 1992-03-23 WO PCT/DK1992/000093 patent/WO1992017473A1/fr active IP Right Grant
- 1992-03-24 US US07/857,038 patent/US5354760A/en not_active Expired - Lifetime
- 1992-03-24 IL IL10135892A patent/IL101358A/en not_active IP Right Cessation
- 1992-03-30 ZA ZA922297A patent/ZA922297B/xx unknown
- 1992-04-01 NZ NZ24219192A patent/NZ242191A/en not_active IP Right Cessation
-
1993
- 1993-09-30 FI FI934298A patent/FI110096B/fi not_active IP Right Cessation
- 1993-10-01 NO NO933524A patent/NO304113B1/no not_active IP Right Cessation
-
1999
- 1999-08-04 GR GR990402003T patent/GR3030919T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH06506209A (ja) | 1994-07-14 |
ATE180781T1 (de) | 1999-06-15 |
NO304113B1 (no) | 1998-10-26 |
FI110096B (fi) | 2002-11-29 |
ES2134801T3 (es) | 1999-10-16 |
NO933524L (no) | 1993-10-01 |
NZ242191A (en) | 1994-07-26 |
DE69229339T2 (de) | 1999-12-30 |
AU1641592A (en) | 1992-11-02 |
DK58291D0 (da) | 1991-04-02 |
FI934298A0 (fi) | 1993-09-30 |
WO1992017473A1 (fr) | 1992-10-15 |
EP0579681A1 (fr) | 1994-01-26 |
DE69229339D1 (de) | 1999-07-08 |
GR3030919T3 (en) | 1999-11-30 |
FI934298A (fi) | 1993-09-30 |
US5354760A (en) | 1994-10-11 |
AU661483B2 (en) | 1995-07-27 |
CA2107223A1 (fr) | 1992-10-03 |
NO933524D0 (no) | 1993-10-01 |
DK0579681T3 (da) | 1999-11-15 |
IL101358A0 (en) | 1992-11-15 |
EP0579681B1 (fr) | 1999-06-02 |
IL101358A (en) | 1996-08-04 |
CA2107223C (fr) | 2005-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA922297B (en) | Crystalline tiababine monohydrate,its preparation and use | |
TW272195B (fr) | ||
IL127244A (en) | Substituted amines, methods of their preparation and pharmaceutical compositions containing them | |
PT915898E (pt) | Forma i cristalina de claritromicina | |
IL128425A0 (en) | Taxane derivatives their preparation and pharmaceutical compositions containing them | |
IL97037A0 (en) | Triazolopyridine containing compounds,process for the preparation thereof and herbicidal compositions containing the same | |
HRP20020330B1 (fr) | ||
IL117091A (en) | Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof | |
WO1992019617A3 (fr) | Composes de dibenzoxazepine substituee, compositions pharmaceutiques et procedes d'utilisation | |
GB2234510B (en) | Ethyl 6-bromo-5-hydroxy-4-dimethylaminomethyl-1-methyl-2-phenylthiomethylindole-3-carboxylate hydrochloride monohydrate, process for & compositions thereof | |
DE69907926D1 (de) | 1,2,4-triazol-3-thion verbindungen | |
HU9401691D0 (en) | 2-oximino-2-phenyl-acetamide derivatives, process for their preparation, their use and fungicidal compositions containing them | |
MX9708394A (es) | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. | |
GB9907571D0 (en) | Compounds | |
TW252979B (fr) | ||
IL109866A (en) | Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it | |
MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
TW218011B (fr) | ||
AP9901472A0 (en) | Crystalline pharmaceutical product. | |
SG153894G (en) | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient | |
TWI231815B (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents | |
AP9600780A0 (en) | Process for the preparation of peroxetine hydrochloride anhydrate and its use as therapeutic agent. | |
HU910063D0 (en) | Process for the production of preparations containing synergetic combination of active agents of natural origin, usable for selective decreasing of blood lipoids |